Clinical trials: Intensive Care Unit Blood Glucose Monitoring
- Condition Intensive Care Unit Blood Glucose Monitoring
- Funder type Industry (pharma, biotech, devices)
Adult Intensive Care Patients
GlySure Acute Care Settings Study
The company who have developed the GlySure product have previously carried out a study to be able to show that the GlySure system is accurate in measuring blood sugar (glucose) levels.
- Trial name
- NCT02421107
- Testing
- Glysure CGM, iStat intermittent testing
- Volunteers
- 40 people
- Sponsor
- GlySure
Blood Glucose
Clinical Study of the Intravenous Blood Glucose System in Hospitalized Adult Elective or Non-Emergent Surgery and Medical/Surgical Intensive Care Unit Patients
The primary objective of this study is to evaluate the performance and safety of the intravenous blood glucose (IVBG) System relative to point of care (POC) meter performance when each method is compared to the Yellow Springs…
- Trial name
- NCT00906490
- Testing
- Intravenous Blood Glucose monitoring system
- Where
- 5 sites in United States
- Volunteers
- 100 people
- Sponsor
- Edwards Lifesciences
Blood Glucose Monitoring in Medical ICU
Comparative Study of GlySure Continuous Intra-vascular Glucose Monitoring and Intermittent Monitoring in Medical ICU
It has been shown that close control of blood glucose levels in the intensive care unit patient has benefits for patient morbidity and mortality rates as well as an impact upon discharge times.
- Trial name
- MICU (NCT02142088)
- Testing
- GlySure Intravascular Continuous glucose monitoring sensor
- Volunteers
- 60 people
- Sponsor
- GlySure
Hyperglycemia
OptiScanner Versus Standard Blood Glucose Monitoring
The study is to demonstrate the accuracy of the OptiScanner in measuring blood glucose levels in critically ill patients when compared to a reference YSI 2300 STAT Plus and the Gem 3000, the reference standard for Erasme…
- Trial name
- NCT01720381
- Where
- Belgium
- Volunteers
- 98 people
- Sponsor
- OptiScan Biomedical Corporation
Continuous Glucose Measurement
A Comparative Study to Evaluate the Accuracy and Safety of the GlySure Continuous Intravascular Glucose Monitoring System Versus Intermittent Blood Glucose Monitoring
The purpose of this study is to evaluate the system performance of the GlySure Continuous Glucose Monitoring (CGM) system in patients admitted to the Surgical Intensive Care Unit.
- Trial name
- NCT01942902
- Testing
- Continuous Glucose Monitoring System
- Where
- 2 sites in India
- Volunteers
- 38 people
- Sponsor
- GlySure
Intensive Care Unit Blood Glucose Monitoring
GlucoClear ICU Study
The primary purpose of this Study is evaluation of the safety and accuracy of the GlucoClear CGM System.
- Trial name
- NCT02238041
- Testing
- GlucoClear System
- Sponsor
- Edwards Lifesciences